WallStreetZenWallStreetZen

NASDAQ: ESLA
Estrella Immunopharma Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

ESLA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$8.4M
Current Profit Margin
0%

ESLA Return on Equity

Insufficient data to display
ESLA's Return on Equity (-690.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ESLA announces earnings.

ESLA Return on Assets

Current Company
-77.9%
Current Industry
2.9%
ESLA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ESLA Return on Capital Employed

Current Company
-92.43%
Current Industry
19.5%

ESLA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ESLA$0.00-$8.36M-$8.36MN/AN/A
ICCC$17.47M-$3.05M-$5.77M+9.72%N/A
SABS$2.24M-$38.13M-$42.19M-8.24%N/A
XLO$0.00-$74.50M-$76.40MN/AN/A
CTCX$0.00-$14.47M-$16.12MN/AN/A
View Top Biotech Stocks

Estrella Immunopharma Earnings & Revenue FAQ

What were ESLA's earnings last quarter?

Estrella Immunopharma (NASDAQ: ESLA) reported Q4 2023 earnings per share (EPS) of -$0.03, up 99.82% year over year. Total Estrella Immunopharma earnings for the quarter were -$1.02 million. In the same quarter last year, Estrella Immunopharma's earnings per share (EPS) was -$16.33.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.

What was ESLA's earnings growth in the past year?

As of Q2 2024, Estrella Immunopharma's earnings has grown year over year. Estrella Immunopharma's earnings in the past year totalled -$8.36 million.

What was ESLA's revenue last quarter?

Estrella Immunopharma (NASDAQ: ESLA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Estrella Immunopharma's revenue was $0.00.

What was ESLA's revenue growth in the past year?

As of Q2 2024, Estrella Immunopharma's revenue has grown null year over year. Estrella Immunopharma's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.